Abstract With the recent introduction of a number of highly effective disease-modifying treatments (DMTs) and the resulting almost complete prevention…
Abstract In patients with multiple sclerosis (MS), a typical pattern of muscle tone alteration, known as spasticity, is frequently observed…
Abstract Background: Nabiximols (THC/CBD Oromucosal Spray, Sativex) is used as an add-on therapy to treat moderate to severe spasticity of…
Abstract The endocannabinoid system (ECS) has been recently recognized as a prominent promoter of the emotional homeostasis, mediating the effects…
Abstract Background: The approval of Sativex for the management of multiple sclerosis (MS) spasticity opened a new opportunity to many…
Abstract The endocannabinoid system plays a regulatory role in a number of physiological processes and has been found altered in…
Abstract Background: Mood disorders, including anxiety and depression, are frequently diagnosed in multiple sclerosis (MS) patients, even independently of the…